Results 121 to 130 of about 1,229,602 (196)

Computational Discovery of MERS-CoV Main Protease Inhibitors Through Screening and Molecular Dynamics Simulations. [PDF]

Proteins
Islam SM, Rahman MS, Singla S, Demissie R, Lee H.   +4 more
europepmc   +1 more source

Characterization of the Cross-Resistance of SARS-CoV‑2 Main Protease Inhibitors, Ibuzatrelvir, Ensitrelvir, and Nirmatrelvir. [PDF]

ACS Pharmacol Transl Sci
Tan H, Chi X, Deng X, Wang J.
europepmc   +1 more source

Longitudinal Clinical and Molecular Characterization of a Single Pediatric Case of Vertically Acquired HIV-1 Subtype C with Baseline Resistance to Protease Inhibitors. [PDF]

Microorganisms
Zaher KA, El-Daly MM, Zaki EA, Alhazmi MM, Abdulhaq A, El-Kafrawy SA, Azhar EI.   +6 more
europepmc   +1 more source

Designing Potent HIV‑1 Protease Inhibitors Using Machine Learning and QSAR Approaches. [PDF]

ACS Omega
Ali S, Dwi Putra I, Chuntakaruk H, Wolschann P, Maitarad P, Rungrotmongkol T, Hannongbua S.   +6 more
europepmc   +1 more source

Residue-Level Affinity Decomposition via Quantum Electron Density: A Multivariable Framework Applied to HIV-1 Protease Inhibitors. [PDF]

J Phys Chem B
Gutiérrez-Flores J, Padilla-Bernal G, Sánchez-Juárez C, Méndez-Orduña DM, Serrano Medina J, García-Gutiérrez P, Zubillaga RA, Vargas R.   +7 more
europepmc   +1 more source

MERS-Mpro Predictor: A Machine Learning-Based Tool for Rapid Screening of Potential MERS-CoV Main Protease Inhibitors. [PDF]

Int J Mol Sci
Ouassaf M, Alhatlani BY.
europepmc   +1 more source

Effect of sonication and protease inhibitors on Elisa quantification of selected proteins in bovine udder tissue homogenates. [PDF]

Sci Rep
Szprynca A, Czopowicz M, Zalewska M, Sakowski T, Kaba J, Bagnicka E.   +5 more
europepmc   +1 more source

Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies. [PDF]

ACS Omega
Hayat K, Qiu D, Wang Y, Imbenzi PS, Khan FI, Matziari M.   +5 more
europepmc   +1 more source

Design and In Vitro Evaluation of Novel GC373-like SARS-CoV-2 Main Protease Inhibitors. [PDF]

Curr Issues Mol Biol
Kuznetsova AA, Makhin AP, Bulygin AA, Andrianova AA, Miturich VS, Zagitova RI, Shmygarev VI, Fadeeva AA, Yatskin ON, Belozerova OA, Smirnov IV, Yampolsky IV, Kaskova ZM, Kuznetsov NA.   +13 more
europepmc   +1 more source

Discovery of protease inhibitors from bacteria as novel adjuvants for oral vaccine formulations. [PDF]

Front Immunol
Coria LM, Pueblas Castro C, Bruno L, Nakaya HI, Pasquevich KA, Cassataro J.   +5 more
europepmc   +1 more source